Krystal Biotech (KRYS) operating margin

Operating margin · fiscal 2025
41.5%

Krystal Biotech (KRYS) had an operating margin of 41.5% in fiscal 2025 (the year ended December 31, 2025). That is 5.9 percentage points higher than the 35.5% of fiscal 2024. Figures as of 17 Nov 2026, 22:33 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Operating margin, fiscal 2025
41.5%
Change on fiscal 2024
+5.9 pts
Highest on record
41.5%fiscal 2025
Lowest on record
-191.6%fiscal 2023
Fiscal years on record
32023–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Krystal Biotech operating margin, in more detail

Across the 3 fiscal years on record (2023–2025), the highest was 41.5% in fiscal 2025 and the lowest -191.6% in fiscal 2023.

Gross margin was 94.1% in fiscal 2025. Net margin was 52.6% in fiscal 2025.

History · 3 fiscal years

Operating margin by fiscal year

  • Operating margin
  • Gross margin
  • Net margin

Krystal Biotech operating margin, year by year

Krystal Biotech (KRYS) operating margin by fiscal year
Fiscal yearOperating marginChangeYear endedGross marginNet margin
202541.5% 5.9 pts up94.1%52.6%
202435.5% 227.1 pts up93.1%30.7%
2023-191.6%—93.9%21.6%

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

How to read it

It shows how much of each unit of sales survives the cost of running the business — rising margins point to pricing power or scale, falling ones to pressure.

Operating margin at health care companies of similar size

Operating margin of Krystal Biotech and comparable companies
CompanyOperating marginFiscal year
Praxis Precision Medicines PRAX-2340.3%2024
Twist Bioscience TWST-36.2%2025
Protagonist Therapeutics PTGX-343.6%2025
Krystal Biotech KRYS41.5%2025
10x Genomics TXG-17.2%2025
HealthEquity HQY24.9%2026

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on KRYS

Krystal Biotech, figure by figure

Krystal Biotech (KRYS) overview: price, valuation and scorecardAll health care companies by market value

Krystal Biotech operating margin: questions and answers

What is Krystal Biotech's operating margin?

Krystal Biotech (KRYS) had an operating margin of 41.5% in fiscal 2025 (the year ended December 31, 2025). That is 5.9 percentage points higher than the 35.5% of fiscal 2024.

What are the highest and lowest operating margin figures on record for Krystal Biotech?

Across the 3 fiscal years on record (2023–2025), the highest was 41.5% in fiscal 2025 and the lowest -191.6% in fiscal 2023.

What are Krystal Biotech's gross and net margins?

Gross margin was 94.1% in fiscal 2025. Net margin was 52.6% in fiscal 2025.

How is Krystal Biotech's operating margin calculated?

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Krystal Biotech (KRYS) operating margin”, data as of 17 November 2026. https://funkfolio.com/stock/KRYS/operating-margin

Underlying data: the company's filings with the SEC and Yahoo Finance.